
Timinta 90mg Tablet
Marketer
Johnlee Pharmaceuticals Pvt Ltd
Salt Composition
Ticagrelor (90mg)
Overview Timinta 90mg Tablet
Cardiogard 90mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the development of dangerous blood clots within blood vessels, thus lowering the risk of stroke or heart attack in individuals with cardiac conditions. Cardiogard 90mg is also prescribed for patients recovering from a recent heart attack, experiencing severe chest pain (unstable angina), or who've received cardiac stents. This medication helps prevent future cardiac events, including further heart attacks, strokes, and clot formation within stents. Concurrent use with aspirin, another antiplatelet medication, is typically prescribed. Cardiogard 90mg can be taken with or without food, consistently at the same time daily; continuous use is crucial, even in the absence of symptoms. Discontinuation may increase the risk of recurrent heart attack or stroke. The most frequent adverse effect is bleeding; injuries may bleed more profusely and for longer periods. Most bleeding episodes are mild and self-limiting. Some patients experience mild shortness of breath, which usually subsides with continued therapy. Report persistent bleeding, worsening or persistent shortness of breath to your physician. Cardiogard 90mg is contraindicated in individuals with active internal bleeding (e.g., stomach ulcers, cerebral hemorrhage) or liver disease. Disclose any such conditions to your doctor before commencing treatment.
Uses of Timinta 90mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Timinta 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Timinta 90mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Timinta 90mg Tablet:
- Bleeding
- Breathlessness
How to use Timinta 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Timinta 90mg Tablets can be consumed with or without food, although consistent daily timing is recommended.
How Timinta 90mg Tablet works:
Each 90mg Timinta tablet inhibits platelet aggregation, a process crucial in blood clot formation. By preventing platelets from clumping, it significantly reduces the risk of cardiovascular events such as stroke and myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Use of Timinta 90mg Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Timinta 90mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Timinta 90mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Timinta 90mg Tablets.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Timinta 90mg tablets are considered safe. No dosage alteration is advised for this medication. Data regarding Timinta 90mg tablet use in individuals undergoing renal dialysis remains limited.
LiverCAUTION
Patients with liver impairment should exercise caution when using Timinta 90mg tablets, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates the use of Timinta 90mg tablets; physician consultation is advised.
What if you forget to take Timinta 90mg Tablet :
Should you forget a Timinta 90mg Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Timinta 90mg Tablet
Label | Value |
---|---|
Chemical Type | Triazolo[1,5-a]pyrimidines |
Developing Habits | No. |
Type of Treatment | KINSHIP |
Actions | ADP receptor antagonists (P2Y12 inhibitors) |